Antibiotic therapy reduces nitrosative stress and programmed cell death in the rabbit foetal lung

European Respiratory Journal

Volumn 25, Issue 1, 2005, Pages 88-95

  Gras Le Guen, Christele ^a,b   Jarry, A ^c   Vallette, G ^c   Toquet, C ^b,c   Colombeix, C ^b   Laoisse, C L ^b,c   Potel, G ^a   Roze, J C ^b   Bugnon, D ^a   Debillon, T ^b  

^a UNIVERSITÉ DE NANTES   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

Author keywords

Antenatal lung inflammation; Antibiotic therapy; Intrauterine infection; Nitric oxide synthase; Oxidative stress

Indexed keywords

3 NITROTYROSINE; CEFTRIAXONE; GENTAMICIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; APOPTOSIS; ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; EPITHELIUM CELL; ESCHERICHIA COLI; FETUS; FETUS LUNG; HISTOLOGY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INOCULATION; INTRAUTERINE INFECTION; LUNG DYSPLASIA; LUNG INFECTION; LUNG INJURY; MATERNAL DISEASE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; DISEASE MODELS, ANIMAL; FEMALE; FETUS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LUNG; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PNEUMONIA, BACTERIAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY, ANIMAL; PROBABILITY; RABBITS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 13444262493     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.10028904     Document Type: Article

References (40)

1. Ohyama M, Itani Y, Yamanaka M, et al. Re-evaluatin of chorioamnionitis and funisitis with a special reference to subacute chorioamnionitis. Hum Pathol 2002; 33: 183-190.
2. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-215.
3. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177: 825-830.
4. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2001; 2: 27-32.
5. Sobel DB, Carroll A. Postsurfactant slump: early prediction of neonatal chronic lung disease? J Perinatol 1994; 14: 268-274.
6. Yoon BH, Romero R, Kim KS, et al. A systemic fetal inflammatory response and the development of broncho-pulmonary dysplasia. Am J Obstet Gynecol 1999; 181: 773-779.
7. Davis JM, Rosenfeld W. Chronic lung disease. In: Avery GB, Fletcher MA, McDonald MD, eds. Neonatology. J.B. Lippincott, Philadelphia, 1999; pp. 509-532.
8. Schmidt B, Cao L, Mackensen-Haen S, Kendziorra H, Klingel K, Speer CP. Chorioamnionitis and inflammation of the fetal lung. Am J Obstet Gynecol 2001; 185: 173-177.
9. Davis JM. Role of oxidant injury in the pathogenesis of neonatal lung disease. Acta Paediatr 2002; 91: Suppl. 437, 23-25.
10. Hargitai B, Szabo V, Hajdu J, et al. Apoptosis in various organs of preterm infants: histopathologic study of lung, kidney, liver, and brain of ventilated infants. Pediatr Res 2001; 50: 110-114.
11. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194-202.
12. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ. Increase in interleukin (IL)-1β and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996; 40: 250-256.
13. Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 29-38.
14. Kinnula VL, Crapo JD, Raivio KO. Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest 1995; 73: 3-19.
15. Hausladen A, Stamler JS. Nitrosative stress. Methods Enzymol 1999; 300: 389-395.
16. Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Ann Rev Physiol 1995; 57: 707-736.
17. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593-615.
18. Wink DA, Grisham MB, Miles AM, et al. Determination of selectivity of reactive nitrogen oxide species for various substrates. Methods Enzymol 1996; 268: 120-130.
19. Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 1998; 101: 870-874.
20. MacRitchie AN, Albertine KH, Sun J, et al. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol l 2001; 281: L1011-L1020.
21. Hopkins L, Smaill F. Antibiotic regimens for management of intraamniotic infection. Cochrane Database Syst Rev 2002 CD003254.
22. Gibbs RS, Davies JK, McDuffie RS Jr, et al. Chronic intrauterine infection and inflammation in the preterm rabbit, despite antibiotic therapy. Am J Obstet Gynecol 2002; 186: 234-239.
23. Gras-Le Guen C, Debillon T, Toquet C, et al. Persistent bacteremia in rabbit fetuses despite maternal antibiotic therapy in a novel intrauterine-infection model. Antimicrob Agents Chemother 2003; 47: 2125-2130.
24. Bingen E, Bonacorsi S, Brahimi N, Denamur E, Elion J. Virulence patterns of Escherichia coli K1 strains associated with neonatal meningitis. J Clin Microbiol 1997; 35: 2981-2982.
25. Bugnon D, Potel G, Caillon J, et al. In vivo simulation of human pharmacokinetics in the rabbit. Bull Math Biol 1998; 60: 545-567.
26. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989; 86: 9030-9033.
27. Weinberg RJ, Valtschanoff JG, Schidt HHW. The NADPH diaphorase histochemical stain. In: Feelisch, Stamler JS, eds. Methods in Nitric Oxide Research. John Wiley and Sons, UK, 1996; pp. 237-248.
28. Moulian N, Truffault F, Gaudry-Talarmain YM, Serraf A, Berrih-Aknin S. In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation. Blood 2001; 97: 3521-3530.
29. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun 2003; 305: 776-783.
30. Lukkarinen HP, Laine J, Kaapa PO. Lung epithelial cells undergo apoptosis in neonatal respiratory distress syndrome. Pediatr Res 2003; 53: 254-259.
31. Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P. Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med 2001; 163: 218-225.
32. Scott JA, McCormack DG. Selective in vivo inhibition of inducible nitric oxide synthase in a rat model of sepsis. J Appl Physiol 1999; 86: 1739-1744.
33. Zhou M, Wang P, Chaudry IH. Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis. Biochim Biophys Acta 1997; 1335: 182-190.
34. Kilbourn RG, Griffith OW. Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 1992; 84: 827-831.
35. Abman SH, Chatfield BA, Hall SL, McMurtry IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990; 259: H1921-H1927.
36. Xue C, Reynolds PR, Johns RA. Developmental expression of NOS isoforms in fetal rat lung: implications for transitional circulation and pulmonary angiogenesis. Am J Physiol 1996; 270: L88-L100.
37. De Paepe ME, Sardesai MP, Johnson BD, Lesieur-Brooks AM, Papadakis K, Luks FI. The role of apoptosis in normal and accelerated lung development in fetal rabbits. J Pediatr Surg 1999; 34: 863-870.
38. Kresch MJ, Christian C, Wu F, Hussain N. Ontogeny of apoptosis during lung development. Pediatr Res 1998; 43: 426-431.
39. Umeki S. Inflammatory action of gentamycin through inhibitory effect on neutrophil NADPH oxidase activity. Comp Biochem Physiol B Biochem Mol Biol 1995; 110: 817-821.
40. Wilschanski M, Yahav Y, Yaacov Y, et al. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 2003; 349: 1433-1441.